Nanologica operates in the field of nanotechnology. Currently the main business focus is on the sectors Drug Delivery and Chromatography, which includes the development of pharmaceutical administration and technology used for the separation and purification of products. The research is carried out in collaboration with Stockholm University and the Ångström Laboratory at Uppsala University. The company was founded in 2004 and is based in Södertälje.

Quotes for Nanologica AB

Right Now

+/-
0.6
%
5,88%
Latest
10.8
High
11
Low
10.5
Volume
35 691
Turnover (SEK)
384 698
Value (MSEK)
179,5

Board

CEO

  • Andreas Bhagwani

Chairman Of The Board

  • Gisela Sitbon

Board

  • Eva Byröd
  • Hans Lennernäs
  • Lena Torlegård
  • Mattias Bengtsson

Videos

Largest Owners

Name Capital % Votes % Date
Thomas Eldered 28,93 28,93 2018-12-31
Andreas Bhagwani 9,55 9,55 2019-09-06
Avanza Pension 5,30 5,30 2019-10-08
Nordnet Pensionsförsäkring 4,55 4,55 2019-06-30
CJ Invest 3,37 3,37 2019-06-30
Alfonso Garcia-Bennett 3,14 3,14 2019-06-30
Mikael Lönn 3,08 3,08 2019-06-30
Niklas Sjöblom 2,08 2,08 2019-06-30
Theodor Jeansson 1,81 1,81 2019-06-30
Kungliga Konstakademien 1,50 1,50 2019-06-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream